Clinical Events in Prostate Cancer Lifestyle Trial: Results From Two Years of Follow-Up

Urology

Volumn 72, Issue 6, 2008, Pages 1319-1323

  Frattaroli, Joanne ^a   Weidner, Gerdi ^b   Dnistrian, Ann M ^d   Kemp, Colleen ^b   Daubenmier, Jennifer J ^e   Marlin, Ruth O ^b   Crutchfield, Lila ^b   Yglecias, Loren ^b   Carroll, Peter R ^c   Ornish, Dean ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Preventive Medicine Research Institute   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FOLLOW UP; GLEASON SCORE; HUMAN; LIFESTYLE MODIFICATION; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STRESS MANAGEMENT; TREATMENT OUTCOME;

AGED; BIOPSY; CELL LINE, TUMOR; DIET; EXERCISE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SELF-HELP GROUPS; TREATMENT OUTCOME;

EID: 56449091793     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.04.050     Document Type: Article

References (28)

1. American Cancer Society. Overview: Prostate Cancer. www.cancer.org/docroot/CRI/content/CRI_2_2_1X_How_many_men_get_prostate_cancer_36.asp?sitearea= Accessed March 7, 2008
2. Bacon C.G., Giovannucci E., Testa M., et al. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer 94 (2002) 862-871
3. Pomerantz M., and Kantoff P. Advances in the treatment of prostate cancer. Annu Rev Med 58 (2007) 205-220
4. Wynder E.L., and Cohen L.A. Correlating nutrition to recent cancer mortality statistics. J Natl Cancer Inst 89 (1997) 324
5. Lund Nilsen T.I., Johnsen R., and Vatten L.J. Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer 82 (2000) 1358-1363
6. Saxe G.A., Hébert J.R., Carmody J.F., et al. Can diet with stress reduction affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer?. J Urol 166 (2001) 2202-2207
7. Demark-Wahnefried W., Price D.T., Polascik T.J., et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: Exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58 (2001) 47-52
8. Giovannucci E., Rimm E.B., Liu Y., et al. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94 (2002) 391-398
9. Yu H., Harris R.E., Gao Y.T., et al. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol 20 (1991) 76-81
10. Ornish D., Lee K.L., Fair W.R., et al. Dietary trial in prostate cancer: Early experience and implications for trial design. Urology 57 (2001) 200-201
11. Ornish D., Weidner G., Fair W.R., et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 174 (2005) 1065-1070
12. Dunn-Emke S.R., Weidner G., Pettengill E.B., et al. Nutritional adequacy of a very low-fat vegan diet. J Am Diet Assoc 105 (2005) 1442-1446
13. Daubenmier J.J., Weidner G., Marlin R., et al. Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology 67 (2006) 125-130
14. Dewell A., Weidner G., Sumner M.D., et al. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the prostate cancer lifestyle trial. Nutr Cancer 58 (2007) 35-42
15. Kronenwetter C., Weidner G., Pettengill E., et al. A qualitative analysis of interviews of men with early stage prostate cancer. Cancer Nurs 28 (2005) 99-107
16. Dewell A., Weidner G., Sumner D., et al. A very low-fat vegan diet increases intake of protective dietary factors and decreases intake of pathogenic dietary factors. J Am Diet Assoc 108 (2008) 347-356
17. Venkitaraman R., Norman A., Woode-Amissah R., et al. Predictors of histological disease progression in untreated, localized prostate cancer. J Urol 178 (2007) 828-832
18. Hoffman R.M., Hunt W.C., Gilliland F.D., et al. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma: Results from the Prostate Cancer Outcomes study. Cancer 97 (2003) 1653-1662
19. Patel M.I., DeConcini D.T., Lopez-Corona E., et al. An analysis of men with clinically localized prostate cancer who deferred definitive treatment. J Urol 171 (2004) 1520-1524
20. Srirangam S.J., Pearson E., Grose C., et al. Partner's influence on patient preference for treatment in early prostate cancer. BJU Int 92 (2003) 365-369
21. D'Amico A.V., Whittington R., Shultz D., et al. Outcome based staging for clinically localized prostate cancer. J Urol 158 (1997) 1422-1426
22. King C.R., Freedland S.J., Terris M.K., et al. Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: A report from search. Urology 69 (2007) 732-737
23. Moul J. The evolving definition of advanced prostate cancer. Rev Urol 6 (2004) S10-S17
24. Warlick C. Identifying candidates for active surveillance: The American experiment. Presented at the UCSF Active Surveillance for Early State Prostate Cancer: Patient Selection, Monitoring, Outcomes, and Opportunity for Novel Research, San Francisco, CA, January 2007.
25. Klotz L.H., and Nam R.K. Active surveillance with selective delayed intervention for favorable risk prostate cancer: Clinical experience and a "number needed to treat" analysis. Can J Urol 13 (2006) 48-55
26. Steineck G., Helgesen F., Adolfsson J., et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347 (2002) 790-796
27. Wilson L.S., Tesoro R., Elkin E.P., et al. Cumulative cost pattern comparison of prostate cancer treatments. Cancer 109 (2007) 518-527
28. Moyad M.A., and Carroll P.R. Lifestyle recommendations to prevent prostate cancer. Part I: Time to redirect our attention?. Urol Clin North Am 31 (2004) 289-300